Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Gilead Sciences, Inc. (GILD) had Free Cash Flow of $9.46B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$29.44B |
|
$8.51B |
|
$6.23B |
|
$23.21B |
|
$19.42B |
|
$10.02B |
|
$-226.00M |
|
$9.80B |
|
$9.80B |
|
$8.51B |
|
$8.51B |
|
$8.51B |
|
$8.51B |
|
$10.02B |
|
$12.78B |
|
1.24B |
|
1.25B |
|
$6.84 |
|
$6.78 |
|
| Balance Sheet Financials | |
$18.34B |
|
$5.61B |
|
$40.68B |
|
$59.02B |
|
$11.81B |
|
$22.13B |
|
$24.59B |
|
$36.41B |
|
$22.62B |
|
$-2.67B |
|
$22.62B |
|
1.24B |
|
| Cash Flow Statement Financials | |
$10.02B |
|
$-4.79B |
|
$-7.75B |
|
$9.99B |
|
$7.56B |
|
$-2.43B |
|
$894.00M |
|
$-4.00B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.55 |
|
-- |
|
-- |
|
0.49 |
|
1.10 |
|
78.83% |
|
34.04% |
|
34.04% |
|
43.41% |
|
33.27% |
|
28.90% |
|
|
Free Cash Flow |
$9.46B |
-- |
|
-- |
|
-- |
|
0.50 |
|
3.51 |
|
5.99 |
|
60.91 |
|
37.62% |
|
-318.25% |
|
14.42% |
|
19.02% |
|
$18.23 |
|
$7.53 |
|
$7.98 |
|